You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 4, April 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Infliximab for the Treatment of Adult-Onset Pityriasis Rubra Pilaris

Wennie C. Liao, MD; Diya F. Mutasim, MD
From the Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Arch Dermatol. 2005;141:423-425.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF CASES

CASE 1

A 77-year-old man presented in June 2002 with a 2-month history of a progressive eruption that initially involved his scalp and progressed to his face, neck, trunk, and extremities. This eruption was associated with chills. His medical history was remarkable for congestive heart failure, hypertension, a mitral valve repair, and gout. His medications included warfarin sodium, digoxin, losartan potassium, hydrochlorothiazide, and terazosin hydrochloride. He had also been taking prednisone and cephalexin prescribed by his primary care physician for his skin condition. Physical examination revealed erythematous, scaly plaques and papules on his scalp, face, neck, upper trunk, and proximal extremities (Figure 1). He had ectropion of both lower eyelids, keratoderma of the palms and soles, and significant pitting edema of the lower extremities. A biopsy specimen was obtained and revealed parakeratosis, moderate acanthosis, and a mild superficial perivascular lymphocytic infiltrate, consistent . . . [Full Text of this Article]

CASE 2

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Clinical Improvement of Pityriasis Rubra Pilaris With Combination Etanercept and Acitretin Therapy
Kristy F. Davis, Jashin J. Wu, Jenny E. Murase, Fredric R. Rosenberg, Erik P. Sorenson, and Azin Meshkinpour
Arch Dermatol. 2007;143(12):1597-1599.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pityriasis Rubra Pilaris Responding Rapidly to Adalimumab
Walling and Swick
Arch Dermatol 2009;145:99-101.
FULL TEXT  

Clinical Improvement of Pityriasis Rubra Pilaris With Combination Etanercept and Acitretin Therapy
Davis et al.
Arch Dermatol 2007;143:1597-1599.
FULL TEXT  

Infliximab as a Therapy for Idiopathic Hypereosinophilic Syndrome
Taverna et al.
Arch Dermatol 2007;143:1110-1112.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.